Powder: -20°C for 3 years | In solvent: -80°C for 1 year
BT44 is a novel, second-generation glial cell line_x0002_derived neurotropic factor mimetic with improved biological activity and is a lead compound for the treatment of neurodegenerative disorders.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 77.00 | |
5 mg | In stock | $ 189.00 | |
10 mg | In stock | $ 297.00 | |
25 mg | In stock | $ 498.00 | |
50 mg | In stock | $ 725.00 | |
100 mg | In stock | $ 987.00 | |
500 mg | In stock | $ 1,980.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 246.00 |
Description | BT44 is a novel, second-generation glial cell line_x0002_derived neurotropic factor mimetic with improved biological activity and is a lead compound for the treatment of neurodegenerative disorders. |
Molecular Weight | 577.59 |
Formula | C28H27F4N3O4S |
CAS No. | 924759-42-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 45 mg/mL (77.91 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
BT44 924759-42-2 Others BT 44 BT-44 RETagonistBT44 inhibitor inhibit